Dr Joshua Sharfstein takes helm at US FDA
This article was originally published in Scrip
Executive Summary
The announcement that Dr Joshua Sharfstein has taken over as US FDA acting commissioner means the agency will have new leadership in place, handpicked by the Obama administration, to tackle key issues before Senate confirmation of a permanent commissioner.